Skip to main content
Clinical Trials/NCT03049436
NCT03049436
Unknown
Not Applicable

Adapted Physical Activity in a Chemotherapy Ambulatory Care Unit: Feasibility and Impact on Fatigue, Anxiety and Depression in Cancer Patients

CHU de Reims1 site in 1 country250 target enrollmentFebruary 1, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Adapted Physical Activity and Cancer
Sponsor
CHU de Reims
Enrollment
250
Locations
1
Primary Endpoint
Feasibility of APA program
Last Updated
9 years ago

Overview

Brief Summary

Physical activity has demonstrated efficacy in cancer prevention and improves quality of life and outcome in cancer survivors. Patients undergoing chemotherapy, especially those with advanced disease, may have symptoms leading to inactivity. Adapted physical activity (APA) among those patients could improve their tolerance to the treatment, and thereby their quality of life. APA could be beneficial to patients with curable disease as well as patients undergoing palliative chemotherapy. Some studies suggest that fighting against loss of muscle mass could lead to a survival benefit. However, APA is not established in daily practice and has not yet been evaluated in a chemotherapy ambulatory care unit.

Primary aim of the study is to assess feasibility of an APA program in a chemotherapy ambulatory care unit of digestive, lung, hematological and dermatological cancers Secondary aim is to measure the impact of an APA program on fatigue, anxiety, depression and handgrip strength in patients beginning chemotherapy or targeted therapy for a digestive, lung, hematological or dermatological cancer, of any stage.

Detailed Description

Assess feasibility of an APA program in a chemotherapy ambulatory care unit of digestive, lung, hematological, and dermatological cancers Measure the impact of an APA program on fatigue, anxiety, depression, handgrip strength

Registry
clinicaltrials.gov
Start Date
February 1, 2017
End Date
February 1, 2018
Last Updated
9 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients beginning chemotherapy or targeted therapy at UMA-CH ambulatory care unit of Reims, CHU, for a digestive, lung, hematological or dermatological cancer, of any stage
  • Patients who agree to participate to the study
  • Major patient

Exclusion Criteria

  • Patient with previous chemotherapy or targeted therapy in the UMA-CH unit
  • Patient under law protection
  • Minor patient
  • Patient with neurological defect preventing from any physical activity

Outcomes

Primary Outcomes

Feasibility of APA program

Time Frame: Day 0

Percentage of patients accepting APA program

Secondary Outcomes

  • fatigue(Month 3)
  • Anxiety(Month 6)
  • Fatigue(Month 6)
  • handgrip strength(Month 6)

Study Sites (1)

Loading locations...

Similar Trials